North America
The North America inhaled corticosteroid device market particularly in the United States and Canada, is witnessing significant growth due to the high prevalence of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). The advanced healthcare infrastructure, along with increased awareness of respiratory health and management, drives demand for inhaled...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian